Opens in a new tab

Breaking news

GLP-1 Drugs Could Reshape Alcohol Consumption And Pub Spending

Alcohol producers and pubs are facing a potential new challenge as GLP-1 medications, widely used for weight loss and diabetes management, appear to be influencing drinking habits. Early research suggests that some users are drinking less, creating pressure for an industry already dealing with declining alcohol consumption in several major markets.

For pubs, the shift could mean adapting to changing customer preferences rather than relying primarily on alcohol sales. Smaller servings, lower-alcohol options and premium drinks may become increasingly important as consumers seek moderation and better-value social experiences.

Alcohol Producers Face Another Demand Challenge

The alcohol industry has been contending with years of declining consumption as health concerns and tighter household budgets encourage people to drink less. GLP-1 medications could add to that pressure.

Heineken said it had discussed the evolving market with UK hospitality businesses as part of its regular engagement with the sector. The brewer noted changes in consumption among GLP-1 users and said it would continue monitoring their behaviour in 2027.

According to Heineken, users are not necessarily giving up alcohol altogether. Instead, some are choosing smaller servings, lower-alcohol drinks and more premium products, reflecting wider trends in the market. The company believes its portfolio is positioned to meet these changing preferences.

UK Pubs Offer Room For Growth

Europe remains Heineken’s largest region by revenue, although growth has been sluggish. The UK has performed comparatively well, with the hospitality sector offering opportunities for the brewer.

A Heineken UK report found that beer generated nearly £14 billion in sales across British pubs, bars and restaurants in the year to February 2026. No- and low-alcohol beer accounted for less than £300 million of that total, indicating that these products still represent a relatively small share of the market.

If drinking habits continue to change, the balance between traditional beer and lower-alcohol alternatives could shift.

Early Data Points To Lower Alcohol Spending

Research is beginning to suggest that GLP-1 use may affect purchasing behaviour. Circana found that US households with at least one GLP-1 user reduced their alcohol spending between 2024 and 2026 compared with households without a user. After two years on the medications, monthly alcohol spending was around 7% lower, while spending on beer fell by approximately 13.5%.

Other major producers remain cautious about drawing firm conclusions. Diageo has told investors that the impact of GLP-1 drugs should remain manageable, even if their use expands. Carlsberg has said available data does not yet establish the medications as a clear driver of beer consumption trends, while Anheuser-Busch InBev declined to comment.

Surveys conducted in Europe and the UK by Circana, NIQ and KAM have also indicated that some GLP-1 users are drinking less.

Users Report Changes In Drinking Habits

In interviews with Reuters, 10 of 11 people taking GLP-1 medications said they had reduced their alcohol consumption, in some cases significantly. Some reported feeling unwell or uncomfortable after drinking, while others said their desire for alcohol had diminished.

Daniel Cornwell, a UK-based founder of hospitality recruitment firm SPE Resourcing, said he previously drank regularly at work events and on weekends. He now finds that alcohol leaves him feeling uncomfortable and can cause hangovers lasting several days.

Joseph Schacht, a professor at the University of Colorado Anschutz who led a randomised controlled trial examining GLP-1 medications and alcohol use disorder, said the drugs may affect brain mechanisms associated with the motivation to drink. He noted that trials involving people with alcohol use disorder have consistently found reductions in cravings and alcohol consumption.

Schacht described the medications as a potential “Prozac moment” for treating alcohol use disorder. However, if reduced cravings extend to a broader population, the trend could also create a challenge for alcohol producers as they adapt to changing consumer behaviour.

Building A Gaming Startup In Cyprus? Plug And Play Opens Applications For Its Second Accelerator

Gaming studios and technology startups in Cyprus can now apply for the second cohort of the Plug and Play Cyprus Accelerator Programme, a three-month initiative offering international mentorship, business development support and access to a global network of investors and corporate partners.

The new cohort will focus on gaming, social and leisure technologies, targeting companies developing games, digital entertainment platforms and technologies supporting the wider gaming industry.

Applications will close on 10 January 2027, with the programme scheduled to begin in Limassol on 8 March.

Implemented by Plug and Play Cyprus, the accelerator is co-funded by the Republic of Cyprus through the Deputy Ministry of Research, Innovation and Digital Policy and the Research and Innovation Foundation (RIF).

Which Startups Can Apply?

The second cohort focuses on gaming and related technologies, with seven areas of interest:

  • Game development: Studios creating PC, console and extended reality (XR) games, from independent productions to larger titles.
  • Mobile and hybrid-casual gaming: Developers using rapid prototyping and data-driven game operations to reach international audiences.
  • Gaming technology: Startups building tools and infrastructure, including game engines, AI, anti-cheat systems, payment technologies and esports platforms.
  • Business intelligence: AI-powered analytics and social listening tools for gaming companies and brands.
  • Immersive technologies: Augmented reality, virtual reality and spatial experiences.
  • Creator economy: Tools supporting streaming, video production and content monetisation.
  • Publishing and distribution: Platforms and services helping developers bring games to market.

The accelerator is seeking startups already established and actively operating in Cyprus, with innovative products or business models capable of expanding internationally.

Applicants should demonstrate significant growth potential, a scalable business model and readiness to attract venture capital investment.

What Does The Programme Offer?

Selected startups will participate in a three-month acceleration programme in Limassol, receiving support from Plug and Play’s international network.

The programme includes:

  • Expert mentorship: Access to experienced entrepreneurs, industry specialists and international mentors.
  • Business development: Personalised feedback on commercial strategy, business models and growth opportunities.
  • Investment opportunities: The chance to explore potential funding with Plug and Play’s investment team.
  • International connections: Access to Plug and Play’s global network of corporate partners, investors and other startups.
  • Workshops and lectures: Sessions covering entrepreneurship, pitching and business development with international experts and experienced founders.

The programme’s timetable includes a Cyprus Expo scheduled for 20 May 2027.

No equity is required to join the accelerator. Selected startups may receive funding to cover programme services through a dedicated RIF scheme that will be announced soon.

The programme does not guarantee investment from Plug and Play.

Building On The First Cohort

The new call follows the completion of Plug and Play Cyprus’s inaugural acceleration programme, which supported ten startups.

According to the organisers, the first cohort received more than 250 hours of mentoring, including 167 in-person, one-to-one sessions, with contributions from more than 25 international mentors.

The programme concluded with the first Plug and Play Cyprus Innovation Expo in Limassol on 11 November, where participating startups presented their progress to investors, corporate representatives and members of the local innovation community.

How To Apply

Applications are open to eligible startups established and actively operating in Cyprus.

Key dates for the second cohort:

  • Application deadline: 10 January 2027
  • Selected cohort announced: 8 February 2027
  • Programme begins: 8 March 2027
  • Cyprus Expo: 20 May 2027
  • Location: Limassol, Cyprus
  • Duration: Three months
  • Equity requirement: None

Following the application deadline, the Plug and Play team will review the applications and present shortlisted companies to its Investment Committee, which will make the final selection. All applicants will be informed of the outcome.

Interested founders can submit their application through the official Plug and Play form.

Further information about the selection criteria, programme benefits and participation conditions is available on the Plug and Play Cyprus Accelerator website.

eCredo
The Future Forbes Realty Global Properties
Uol
Aretilaw firm

Become a Speaker

Become a Speaker

Become a Partner

Subscribe for our weekly newsletter